Current treatment options for patients with initially unresectable isolated colorectal liver metastases

被引:10
作者
Kanat, Ozkan [1 ]
机构
[1] Uludag Univ, Fac Med, Dept Med Oncol, TR-16059 Gorukle, Bursa, Turkey
来源
WORLD JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 7卷 / 01期
关键词
Colorectal cancer; Conversion therapy; Liver metastases; Targeted therapy; Hepatic arterial infusion;
D O I
10.5306/wjco.v7.i1.9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The development of liver metastases is a common clinical entity in the clinical course of colorectal cancer. For patients with isolated liver involvement, surgical resection is the only treatment that can provide a chance of prolonged survival and cure. However, most of these patients are not initially eligible for the surgery. Selected patients with initially considered to have unresectable disease may become resectable after systemic (chemotherapy +/- biological therapy) and loco-regional treatment modalities including hepatic arterial infusion. Patients who have colorectal liver metastases ideally should be referred to a multidisciplinary cancer care team in order to identify the most optimal management approach.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [31] Current state of surgical treatment of liver metastases from colorectal cancer
    Grundmann, Reinhart T.
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2011, 3 (12): : 183 - 196
  • [32] Neoadjuvant treatment of unresectable colorectal liver metastases:: correlation between tumour response and resection rates
    Folprecht, G
    Grothey, A
    Alberts, S
    Raab, HR
    Köhne, CH
    ANNALS OF ONCOLOGY, 2005, 16 (08) : 1311 - 1319
  • [33] Hepatic arterial infusion (HAI) of cisplatin and systemic fluorouracil in the treatment of unresectable colorectal liver metastases
    Mancini, R
    Tedesco, M
    Garufi, C
    Filippini, A
    Arcieri, S
    Caterino, M
    Pizzi, G
    Cortesi, E
    Spila, A
    Sperduti, I
    Cosimelli, M
    ANTICANCER RESEARCH, 2003, 23 (2C) : 1837 - 1841
  • [34] A contemporary systematic review on liver transplantation for unresectable liver metastases of colorectal cancer
    Lebeck Lee, Cody M.
    Ziogas, Ioannis A.
    Agarwal, Rajiv
    Alexopoulos, Sophoclis P.
    Ciombor, Kristen K.
    Matsuoka, Lea K.
    Brown, Daniel B.
    Eng, Cathy
    CANCER, 2022, 128 (12) : 2243 - 2257
  • [35] Prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases
    Park, Jun Su
    Park, Hee Chul
    Choi, Doo Ho
    Park, Won
    Il Yu, Jeong
    Park, Young Suk
    Kang, Won Ki
    Park, Joon Oh
    RADIATION ONCOLOGY JOURNAL, 2014, 32 (02): : 77 - 83
  • [36] Current status of surgical treatment of colorectal liver metastases
    Xu, Feng
    Tang, Bin
    Jin, Tian-Qiang
    Dai, Chao-Liu
    WORLD JOURNAL OF CLINICAL CASES, 2018, 6 (14) : 716 - 734
  • [37] Current status of surgical treatment of colorectal liver metastases
    Feng Xu
    Bin Tang
    Tian-Qiang Jin
    Chao-Liu Dai
    World Journal of Clinical Cases, 2018, (14) : 716 - 734
  • [38] Treatment of Colorectal Cancer with Unresectable Synchronous Liver-Only Metastases with Combined Therapeutic Modalities
    Yunlong Cui
    Huikai Li
    Qiang Wu
    Ti Zhang
    Dalu Kong
    Tianqiang Song
    Tao Ru
    Ping Chen
    Qiang Li
    Journal of Gastrointestinal Surgery, 2011, 15 : 285 - 293
  • [39] Long-Term Results of Hepatectomy After Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatic Colorectal Metastases
    Fujimoto, Yoshiya
    Akasu, Takayuki
    Yamamoto, Seiichiro
    Fujita, Shin
    Moriya, Yoshihiro
    JOURNAL OF GASTROINTESTINAL SURGERY, 2009, 13 (09) : 1643 - 1650
  • [40] Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients
    Coskun, U.
    Buyukberber, S.
    Yaman, E.
    Uner, A.
    Er, O.
    Ozkan, M.
    Dikilitas, M.
    Oguz, M.
    Yildiz, R.
    Yamac, D.
    Ozturk, B.
    Kaya, A. O.
    Benekli, M.
    NEOPLASMA, 2008, 55 (01) : 65 - 70